These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33315713)

  • 21. Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008-2015
    Zanichelli V; Garenc C; Villeneuve J; Moisan D; Frenette C; Loo V; Longtin Y;
    Emerg Infect Dis; 2020 Jun; 26(6):1291-1294. PubMed ID: 32441632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
    Khanna S; Pardi D
    Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
    [No Abstract]   [Full Text] [Related]  

  • 23. Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated
    Cho YS
    Gut Liver; 2021 Jan; 15(1):1-2. PubMed ID: 33443235
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrent Clostridioides difficile Infections: Should We Respond More to Toxin B?
    Schriever CA; Danziger LH
    Clin Infect Dis; 2020 Jun; 71(1):87-88. PubMed ID: 31584630
    [No Abstract]   [Full Text] [Related]  

  • 25. Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong.
    Guo CLT; Kwong TNY; Mak JWY; Zhang L; Lui GCY; Wong GLH; Ip M; Yu J; Sung JJY; Wu WKK; Wong SH
    Emerg Infect Dis; 2021 Dec; 27(12):3036-44. PubMed ID: 34812719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal Microbiota Transplantation "Donor Effects" Are Not Clinically Relevant for Clostridioides difficile Infection.
    Olesen SW
    Gastroenterology; 2021 Jun; 160(7):2635-2636. PubMed ID: 33387515
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of testing methods on incidence of
    McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridioides Difficile Infection.
    Ferrari L; Fichera A
    Dis Colon Rectum; 2021 Feb; 64(2):151-155. PubMed ID: 33315710
    [No Abstract]   [Full Text] [Related]  

  • 29. Holding firm: Use of clinical correlation to improve Clostridioides difficile testing.
    Baghdadi J; Ganz DA; Chumpia M; Chang ET; de Peralta SS
    Am J Infect Control; 2020 Sep; 48(9):1104-1107. PubMed ID: 31862165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual Gastrointestinal Symptoms after Fecal Microbiota Transplantation for Clostridioides difficile Infection: A Matter of Efficacy Rather Than Safety?
    Ianiro G; Giambò F; Cammarota G
    Gastroenterology; 2021 Oct; 161(4):1344. PubMed ID: 34090885
    [No Abstract]   [Full Text] [Related]  

  • 31. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection.
    Kunishima H; Ohge H; Suzuki H; Nakamura A; Matsumoto K; Mikamo H; Mori N; Morinaga Y; Yanagihara K; Yamagishi Y; Yoshizawa S
    J Infect Chemother; 2022 Aug; 28(8):1045-1083. PubMed ID: 35618618
    [No Abstract]   [Full Text] [Related]  

  • 32. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults: Treat Early, Treat Often.
    Agrawal G
    Dig Dis Sci; 2020 Dec; 65(12):3425-3427. PubMed ID: 32356257
    [No Abstract]   [Full Text] [Related]  

  • 33. Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent
    Satokari R; Pietilä L; Mattila E; Lahtinen P; Arkkila PET
    Infect Dis (Lond); 2020 Sep; 52(9):662-665. PubMed ID: 32516025
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Weese JS
    J Vet Diagn Invest; 2020 Mar; 32(2):213-221. PubMed ID: 31904312
    [No Abstract]   [Full Text] [Related]  

  • 35. Community-onset Clostridioides difficile infection in a pregnant woman without traditional risk factors.
    Tsai WC; Tsai PJ; Tsai BY; Tsai CS; Chen PL; Lee NY; Ko WC; Syue LS
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1188-1189. PubMed ID: 34099421
    [No Abstract]   [Full Text] [Related]  

  • 36. Can Clostridium innocuum Masquerade as Clostridioides difficile?
    Skinner AM; Petrella L; Spandoni S; Serna-Perez F; Johnson S
    Clin Infect Dis; 2022 Sep; 75(7):1268-1269. PubMed ID: 35579505
    [No Abstract]   [Full Text] [Related]  

  • 37. Achieving and maintaining low rates of hospital-onset
    LaPorte MRC; Bruno-Murtha LA
    Infect Control Hosp Epidemiol; 2020 Aug; 41(8):995-997. PubMed ID: 32408913
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel and emerging sources of Clostridioides difficile infection.
    Turner NA; Smith BA; Lewis SS
    PLoS Pathog; 2019 Dec; 15(12):e1008125. PubMed ID: 31856240
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases.
    Doll M; Marra AR; Apisarnthanarak A; Al-Maani AS; Abbas S; Rosenthal VD
    Int J Infect Dis; 2021 Jan; 102():188-195. PubMed ID: 33122100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Updates on
    Marino D; Kelly CR
    Ann Intern Med; 2022 Sep; 175(9):HO2-HO3. PubMed ID: 36122397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.